Hector Franco, PhDUniversity of North Carolina, Chapel Hill2022 Lester and Bernice Smith Pilot Study Award Identifying Drivers of Therapeutic Resistance in Ovarian Cancer at Single-Cell Resolution Ovarian cancer is one of the deadliest cancers among women worldwide. Most women respond well to the standard treatment; however, up to 75% of these patients experience a recurrence […]
Read More
Gianpietro Dotti, M.D.The University of North Carolina at Chapel Hill Targeting B7-H3 in Ovarian Cancer Ovarian cancer is an aggressive type of tumor for which no effective therapy is currently available when the disease comes back after chemotherapy and surgery. This has prompted Dr. Dotti to develop a strategy in which the immune system will […]
Read More